Umbilical Cord-derived Mesenchymal Stromal Cell Therapy (State-Financed Health Facility Samara Regional Medical Center Dinasty)

N/A

Report date: 2023/01/12 15:46:25

Base Information

Drug NameUmbilical Cord-derived Mesenchymal Stromal Cell Therapy (State-Financed Health Facility Samara Regional Medical Center Dinasty)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derived

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsHeart FailureCardiomyopathiesCardiomyopathy, Dilated

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryKazakhstan

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesThe Research-Clinical Center For Cardiac Surgery And Transplantology Llp State-Financed Health Facility Samara Regional Medical Center Dinasty

China Registration ClassN/A

Develop Information

Active CompaniesThe Research-Clinical Center For Cardiac Surgery And Transplantology Llp State-Financed Health Facility Samara Regional Medical Center Dinasty

Inactive CompaniesN/A

Active IndicationsHeart FailureCardiomyopathiesCardiomyopathy, Dilated

Inactive IndicationsN/A

Other Information

ATC CodeN/A